Our Clinical Trials Site Value Driver Report highlights the key factors that drive valuation for independent clinical trials site businesses. It breaks down the most important qualitative and quantitative value drivers:

• Qualitative Drivers: depth and pipeline of principal investigators; a reliable patient enrollment strategy; a clear therapeutic-area strategy (either niche or diversified); a strong, energetic management team; independence from physician practices; and financial discipline (GAAP reporting, cash visibility, quality of earnings).

• Quantitative Metrics: book-to-bill ratio (backlog vs existing contracts), net revenue retention, revenue growth rate, EBITDA margin, customer concentration (especially % from top-3 customers), and employee turnover.

In short, the scorecard offers a practical framework for owner-operators of trials site businesses to assess how attractive a clinical-site business is to potential investors/partners.